MURUGAPPAN M, BABU B, SHANKAR V, YUSUF M, and JAWAHAR N. 2025. “ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT”. Asian Journal of Pharmaceutical and Clinical Research 18 (4):44-51. https://doi.org/10.22159/ajpcr.2025v18i4.54004.